Drug combinations for malaria: time to ACT?
Duffy
Patrick E
PE
Malaria Antigen Discovery Program, Seattle Biomedical Research Institute, WA 98109, Seattle, USA. patrick.duffy@sbri.org
Mutabingwa
Theonest K
TK
D000349:Africa / Q000453:epidemiology; D000962:Antimalarials / Q000008:administration & dosage / Q000627:therapeutic use*; D037621:Artemisinins / Q000008:administration & dosage / Q000627:therapeutic use; D001210:Asia, Southeastern / Q000453:epidemiology; D021821:Communicable Diseases, Emerging / Q000188:drug therapy; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D006801:Humans; D015994:Incidence; D008288:Malaria / Q000188:drug therapy* / Q000453:epidemiology; D016778:Malaria, Falciparum / Q000188:drug therapy / Q000453:epidemiology; D018512:Parasitemia / Q000188:drug therapy; D012717:Sesquiterpenes / Q000008:administration & dosage / Q000627:therapeutic use
D000962:Antimalarials; D037621:Artemisinins; D012717:Sesquiterpenes; C031327:artemisinin